Multidrug-resistance-associated protein 1 (Mrp1) is probably not required for murine Th cell activation

International Immunology

Volumn 18, Issue 11, 2006, Pages 1603-1606

  Kleemann, Peter ^a   Casper, Baerbel ^a   Huber, Magdalena ^a   Schuetz, John D ^b   Lohoff, Michael ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MULTIDRUG RESISTANCE PROTEIN 1; VERLUKAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE DIFFERENTIATION; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; WILD TYPE;

ANIMALS; ANTI-ASTHMATIC AGENTS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROPIONATES; QUINOLINES; TH1 CELLS;

EID: 33750210646     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl094     Document Type: Article

References (14)

1. Cole, S. P., Bhardwaj, G., Gerlach, J. H. et al. 1992. Over-expression of a transporter gene in a multidrug-resistant human lung cancer cell line [see comments]. Science 258:1650.
2. Lohoff, M., Prechtl, S., Sommer, F. et al. 1998. A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. J. Clin. Invest. 101:703.
3. 1 cells. J. Immunol. 164:754.
4. Reiner, S. L. and Locksley, R. M. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
5. Zhang, J., Alston, M. A., Huang, H. and Rabin, R. L. 2006. Human T cell cytokine responses are dependent on multidrug resistance protein-1. Int. Immunol. 18:485.
6. Wijnholds, J., Evers, R., van Leusden, M. R. et al. 1997. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3:1275.
7. Lohoff, M., Ferrick, D., Mittrucker, H. W. et al. 1997. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6:681.
8. Lohoff, M., Duncan, G. S., Ferrick, D. et al. 2000. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J. Exp. Med. 192:325.
9. Conseil, G., Deeley, R. G. and Cole, S. P. 2005. Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. Pharmacogenet. Genomics 15:523.
10. Reid, G., Wielinga, P., Zelcer, N. et al. 2003. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol. Pharmacol. 63:1094.
11. Elliott, J. I., Raguz, S. and Higgins, C. F. 2004. Multidrug transporter activity in lymphocytes. Br. J. Pharmacol. 143:899.
12. Jones, T. R., Zamboni, R., Belley, M. et al. 1989. Pharmacology of L-660,711 (MK-571): A novel potent and selective leukotriene D4 receptor antagonist. Can. J. Physiol. Pharmacol. 67:17.
13. Robbiani, D. F., Finch, R. A., Jager, D., Muller, W. A., Sartorelli, A. C. and Randolph, G. J. 2000. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103:757.
14. ten Hove, T., Drillenburg, P., Wijnholds, J., Te Velde, A. A. and van Deventer, S. J. 2002. Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis. Dig. Dis. Sci. 47:2056.